Profit before tax jumped 51.1% to Rs 147.87 crore in Q4 FY23 as compare with Rs 97.84 crore in previous quarter last year.

Emami said that the FMCG industry witnessed a mixed demand environment in Q4FY23, as discretionary categories like personal care continued to remain muted on account of reduction of nonessential expenditure by rural consumers. Additionally, excessive rainfall in many areas of the country in March impacted the demand for summer products.

India business grew by 5% during the quarter. Excluding the sales of healthcare and pain management range which had a higher consumption during COVID period, domestic sales grew by 11%. New age channels like modern trade and eCommerce continued to perform well, growing by 18% and 64% respectively over previous year.

International business grew by 19% during the quarter despite high inflation, currency depreciation and geopolitical challenges in several key markets.The growth was mainly driven by strong performances in markets of MENA, CIS and Bangladesh.

EBIDTA stood at Rs 199.81 crore grew by 22% with EBIDTA margins at 23.9% expanding by 260 bps. Profit before Tax in Q4 FY23 stood at Rs 148 crore, up 51% from Rs 97.84 croreQ4 FY22.

On full year basis, the FMCG company's net profit dropped 23.8% to Rs 639.57 crore despite of 9.7% jump in revenue from operations to Rs 3,405.73 crore in FY23 over FY22.

Harsha V Agarwal, vice chairman and managing director, Emami, said, “Our strategic investments and Dermicool acquisition have performed well and contributed to this growth. We will continue to make significant investment behind our core brands, innovations, channel expansions and digital optimisations which are expected to contribute immensely to future growth.”

Emami is one of India's leading FMCG Companies engaged in manufacturing & marketing of personal care & healthcare products. Its portfolio includes brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm & Mentho Plus. In 2015, the Company acquired the business of 'Kesh King' and forayed into the Ayurvedic hair & scalp care segment. In, 2019, the company acquired Creme 21, a German brand with strong roots & brand recall.

The scrip rose 1.12% to Rs 389.30 on the BSE.